Laura Pazzaglia

8PUBLICATIONS
53CO-AUTHORS
Gene and molecular therapySolid tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center Experience.

Alessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra

|Aug 12, 2023
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma.

Lorena Landuzzi, Maria Cristina Manara, Laura Pazzaglia

|Jul 11, 2023
Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.

Teresa González-Muñoz, Angela Di Giannatale, Susana García-Silva

|Jun 24, 2022
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.

Emanuela Palmerini, Laura Pazzaglia, Luca Cevolani

|Apr 12, 2022
miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness.

Alessandra De Feo, Laura Pazzaglia, Lisa Ciuffarin

|Dec 23, 2021
Cytotoxicity of an Innovative Pressurised Cyclic Solid-Liquid (PCSL) Extract from Artemisia annua.

Rosanna Culurciello, Andrea Bosso, Giovanni Di Fabio

Pageof 2

Frequent Collaborators

7 joint publications

Katia Scotlandi

2 joint publications

Leonardo Leonardi

2 joint publications

Evelin Pellegrini

2 joint publications

Marco Gambarotti